AIDS Society of India urges government to include HIV self-testing in policies
New Delhi, Oct 18 (IANS) The AIDS Society of India (ASI) on Friday urged the government to include HIV self-testing and pre-exposure prophylaxis (PrEP) medicine, taken to prevent from HIV, in its policies and programmes without much delay. One in five people living with HIV in the country do not know their HIV status. The
New Delhi, Oct 18 (IANS) The AIDS Society of India (ASI) on Friday urged the government to include HIV self-testing and pre-exposure prophylaxis (PrEP) medicine, taken to prevent from HIV, in its policies and programmes without much delay.
One in five people living with HIV in the country do not know their HIV status. The World Health Organisation (WHO) recommended HIV self-testing as part of HIV care cascade as it is an important approach to address gaps in HIV diagnoses, especially among key populations, in 2019.
“We need to ensure that 100 per cent of people living with HIV know their status so that they can receive full cascade of HIV care services and stay virally suppressed (undetectable viral load) – which is essential for them to live full and healthy lives – as well as to end AIDS,” said Dr Ishwar Gilada, President-Emeritus, AIDS Society of India (ASI).
According to government’s fifth edition of National AIDS Control Organisation’s (NACO) ‘Sankalak report 2023’, 79 per cent of people living with HIV (PLHIV) knew their status, 86 per cent of them were on antiretroviral therapy and 93 per cent of them had viral suppression.
The ASI said that this translates into 63 per cent of total PLHIV in India being virally suppressed in 2023 against the target of getting 86 per cent of them virally suppressed by 2025.
“India’s role in the global prevention of HIV-related deaths is unmatched and laudable. However, almost 92 per cent of people living with HIV (PLHIV) and persons at risk of contracting HIV globally are consuming ‘made-in-India’ anti-retrovirals (ARVs),” claimed Dr Gilada.
Recent success story of twice yearly shots of Lenacapavir preventing HIV in over 96 per cent of at risk people and the Gilead granting royalty-free voluntary licenses to six generic pharma globally including four Indian, hit headlines.
“How India benefits from it remains in doldrums, as PrEP is not part of its National AIDS Control Programme (NACP). Although the HIV infections in India were declining with the wide-scale implementation of ART through 750 government-run ART centres, HIV cases started rising since 2020, with high burden in young people,” Gilada emphasised.
According to the ASI, HIV prevalence among migrants is 4 times, among truckers is 5 times, among inmates in central jails and female sex workers is 9 times, among men who have sex with men (MSM) is 16 times, among hijra/transgender people is 18 times and among people who use drugs is 43 times of the overall adult HIV prevalence.
–IANS
na/
Odisha Govt Reconstitutes Task Force to Suggest Measures for Implementation of National Education Policy 2020
Next ArticleCongress directs Charan Das Mahant to submit report on organisational affairs of Odisha unit
Related Articles
Study decodes why promising cancer treatments trigger serious side effects

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀStudy decodes why promising cancer treatments trigger serious side effects
New Delhi: While cancer has seen some significant advancements in treatments that have shown promise and increased lifespan, however, it also causes serious side effects, which can affect quality of life. A new study by researchers from Australia is shedding new light on the reasons behind these side effects, Xinhua news agency reported. The team
Covid hospitalisation, family history, lifestyle behaviours behind unexplained sudden death: ICMR study

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀCovid hospitalisation, family history, lifestyle behaviours behind unexplained sudden death: ICMR study
New Delhi: Hospitalisations due to severe Covid-19 infection, a family history of sudden deaths, as well as lifestyle behaviours are some of the reasons behind the unexplained sudden death, according to a study led by the Indian Council of Medical Research (ICMR). The peer-reviewed study published in the Indian Journal of Medical Research explored factors
ICMR, AIIMS studies found no link between Covid vaccine & sudden deaths: Centre

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀICMR, AIIMS studies found no link between Covid vaccine & sudden deaths: Centre
New Delhi: Extensive studies undertaken by the Indian Council of Medical Research (ICMR), and All India Institute of Medical Sciences (AIIMS) have conclusively established no link between Covid-19 vaccines and sudden deaths, the Ministry of Health and Family Welfare said on Wednesday. Post the Covid pandemic several cases of heart attack-related death among people, especially
